No Data
No Data
No Data
No Data
No Data
Press Release: Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of EUR79.6m, up +6.1% at Constant Exchange Rates
Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of EUR79.6m, up +6.1% at Constant Exchange Rates -- Growth of 1.2% at constant exchange rates for the third quarter of FY 2023
Dow JonesApr 18 12:00 ET
Amplitude Is Maintained at Underweight by Morgan Stanley
Amplitude Is Maintained at Underweight by Morgan Stanley
Dow JonesApr 17 13:06 ET
Demystifying Amplitude: Insights From 4 Analyst Reviews
4 analysts have shared their evaluations of Amplitude (NASDAQ:AMPL) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below offers a condensed view of thei
BenzingaApr 17 13:01 ET
Morgan Stanley Maintains Underweight on Amplitude, Lowers Price Target to $10
Morgan Stanley analyst Elizabeth Porter maintains Amplitude (NASDAQ:AMPL) with a Underweight and lowers the price target from $12 to $10.
BenzingaApr 17 12:56 ET
Express News | Amplitude Inc : Morgan Stanley Cuts Target Price to $10.00 From $12.00
Moomoo 24/7Apr 17 06:10 ET
Amplitude to Host First Quarter 2024 Earnings Webcast on May 9, 2024
Amplitude, Inc. (NASDAQ:AMPL), a leading digital analytics platform, today announced that it will release its financial results for the first quarter of 2024 after market close on Thursday, May 9, 2024. Amplitude will
BusinesswireApr 16 09:00 ET
No Data
No Data